References
- Cailotto C, Lei J, van der Vliet J, et al. (2009). Effects of nocturnal light on (clock) gene expression in peripheral organs: A role for the autonomic innervation of the liver. PLoS One. 4:e5650
- Conlon M, Lightfoot N, Kreiger N. (2007). Rotating shift work and risk of prostate cancer. Epidemiology. 18:182–3
- Cucina A, Proietti S, D'Anselmi F, et al. (2009). Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J Pineal Res. 46:172–80
- Davidson AJ, Sellix MT, Daniel J, et al. (2006). Chronic jet-lag increases mortality in aged mice. Curr Biol. 16:R914–16
- DeBruyne JP, Noton E, Lambert CM, et al. (2006). A clock shock: Mouse CLOCK is not required for circadian oscillator function. Neuron. 50:465–77
- de la Iglesia HO, Cambras T, Schwartz WJ, Diez-Noguera A. (2004). Forced desynchronization of dual circadian oscillators within the rat suprachiasmatic nucleus. Curr Biol. 14:796–800
- Filipski E, Delaunay F, King VM, et al. (2004). Effects of chronic jet lag on tumor progression in mice. Cancer Res. 64:7879–85
- Filipski E, Innominato PF, Wu M, et al. (2005). Effects of light and food schedules on liver and tumor molecular clocks in mice. J Natl Cancer Inst. 97:507–17
- Filipski E, Subramanian P, Carriere J, et al. (2009). Circadian disruption accelerates liver carcinogenesis in mice. Mutat Res. 680:95–105
- Fraser S, Cowen P, Franklin M, et al. (1983). Direct radioimmunoassay for melatonin in plasma. Clin Chem. 29:396–7
- Fritschi L, Glass DC, Heyworth JS, et al. (2011). Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 77:430–6
- Fu L, Pelicano H, Liu J, et al. (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 111:41–50
- Gery S, Virk RK, Chumakov K, et al. (2007). The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene. 26:7916–20
- Goto M, Matsuo H, Iigo M, et al. (2013). Melatonin-induced changes in the expression of thyroid hormone-converting enzymes in hypothalamus depend on the timing of melatonin injections and genetic background in mice. Gen Comp Endocrinol. 186:33–40
- Herr I, Gassler N, Friess H, Buchler MW. (2007). Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis. 12:271–91
- Hill SM, Frasch T, Xiang S, et al. (2009). Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther. 8:337–46
- Hua H, Wang Y, Wan C, et al. (2006). Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 97:589–96
- Jung B, Ahmad N. (2006). Melatonin in cancer management: Progress and promise. Cancer Res. 66:9789–93
- Jung-Hynes B, Huang W, Reiter RJ, Ahmad N. (2010). Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res. 49:60–8
- Karatsoreos IN, Bhagat S, Bloss EB, et al. (2011). Disruption of circadian clocks has ramifications for metabolism, brain, and behavior. Proc Natl Acad Sci USA. 108:1657–62
- Kennaway DJ, Voultsios A, Varcoe TJ, Moyer RW. (2002). Melatonin in mice: Rhythms, response to light, adrenergic stimulation, and metabolism. Am J Physiol Regul Integr Comp Physiol. 282:R358–65
- Kiessling S, Eichele G, Oster H. (2010). Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag. J Clin Invest. 120:2600–9
- Kubo T, Ozasa K, Mikami K, et al. (2006). Prospective cohort study of the risk of prostate cancer among rotating-shift workers: Findings from the Japan collaborative cohort study. Am J Epidemiol. 164:549–55
- Lamia KA, Papp SJ, Yu RT, et al. (2011). Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature. 480:552–6
- Li X M, Liu XH, Filipski E, et al. (2000). Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F(1) mice. Am J Physiol Regul Integr Comp Physiol. 278:R924–30
- Logan RW, Zhang C, Murugan S, et al. (2012). Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. J Immunol. 188:2583–91
- Matsuo T, Yamaguchi S, Mitsui S, et al. (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science. 302:255–9
- Mediavilla MD, Cos S, Sanchez-Barcelo EJ. (1999). Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci. 65:415–20
- Minami Y, Kasukawa T, Kakazu Y, et al. (2009). Measurement of internal body time by blood metabolomics. Proc Natl Acad Sci USA. 106:9890–5
- Mohawk JA, Green CB, Takahashi JS. (2012). Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. 35:445–62
- Nader N, Chrousos GP, Kino T. (2009). Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: Potential physiological implications. FASEB J. 23:1572–83
- Nakahara D, Nakamura M, Iigo M, Okamura H. (2003). Bimodal circadian secretion of melatonin from the pineal gland in a living CBA mouse. Proc Natl Acad Sci USA. 100:9584–9
- Nemeth C, Humpeler S, Kallay E, et al. (2011). Decreased expression of the melatonin receptor 1 in human colorectal adenocarcinomas. J Biol Regul Homeost Agents. 25:531–42
- Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
- Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature. 418:935–41
- Schernhammer ES, Laden F, Speizer FE, et al. (2001). Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 93:1563–8
- Schernhammer ES, Laden F, Speizer FE, et al. (2003). Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 95:825–8
- Shearman LP, Sriram S, Weaver DR, et al. (2000). Interacting molecular loops in the mammalian circadian clock. Science. 288:1013–19
- Subramanian A, Kothari L. (1991). Melatonin, a suppressor of spontaneous murine mammary tumors. J Pineal Res. 10:136–40
- Viswanathan AN, Schernhammer ES. (2009). Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett. 281:1–7
- Vijayalaxmi, Thomas CR Jr., Reiter RJ, Herman TS. (2002). Melatonin: From basic research to cancer treatment clinics. J Clin Oncol. 20:2575–601